Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.

HIV medicine - 1 Sept 2010

Hosseinipour M C, Kumwenda J J, Weigel R, Brown L B, Mzinganjira D, Mhango B, Eron J J, Phiri S, van Oosterhout J J

Abstract excerpt

OBJECTIVES: The Malawi antiretroviral therapy (ART) programme uses the public health approach to identify ART failure. Advanced disease progression may occur before switching to second-line ART. We report outcomes for patients evaluated and initiated on second-line treatment in Malawi. METHODS: Patients meeting Malawi immunological or clinical criteria for ART failure in two large urban ART clinics were evaluated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Developing Countries

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Malawi

Share to Medication Adherence

Share to National Health Programs

Share to Organophosphonates

Share to Tenofovir

Share to Urban Population

Source

Open in PubMed Open full text

Identifiers

PMID: 20345885
DOI: 10.1111/j.1468-1293.2010.00825.x
PMCID: PMC4833877

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.PMID 20345885Read ↗

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.Semantic proximity Read ↗

Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi.Semantic proximity Read ↗

Determinants of virological failure and antiretroviral drug resistance in Mozambique.Semantic proximity Read ↗

An audit of the HIV drug resistance testing program in Malawi.Semantic proximity Read ↗

Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.Semantic proximity Read ↗

Predictors of Failure on Second-line Antiretroviral Therapy with Protease Inhibitor Mutations in UgandaSemantic proximity Read ↗

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial.Semantic proximity Read ↗

Outcome of patients on second line antiretroviral therapy under programmatic condition in India.Semantic proximity Read ↗

Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes.Semantic proximity Read ↗

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda.Semantic proximity Read ↗

High prevalence of virological failure and HIV drug mutations in a first-line cohort of Malawian children.Semantic proximity Read ↗

Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.